Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Shares Slide 7.4 Percent Despite 90-Percent Profit Jump

NEW YORK, May 3 (GenomeWeb News) - Shares in Bruker Daltonics were down 7.39 percent, or $.44, at $5.51, despite the company posting a 90-percent jump in first-quarter profits.

 

As GenomeWeb News reported this morning, Bruker said first-quarter revenue declined less than 1 percent to $74.4 million from $74.9 year over year.

 

Profit in the quarter rose to $776,000 from $417,000 in the year-ago period.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.